|$JNCE $XBIT whose deal is better?||
||12/09/2019 8:20:08 AM|
|$JNCE Time to short||
||12/04/2019 1:12:11 PM|
|$JNCE break 8.41 PT 8.50 - 8.65||
||12/04/2019 11:42:11 AM|
|$JNCE Sorry bulls. this company is pump and dump at best||
||07/24/2019 10:04:20 AM|
|#PM Movers $JNCE 31%,$SNAP 16%,$VISL 12%,$TRNX 11%||
||07/24/2019 9:06:20 AM|
Jounce Therapeutics Inc. Company Name:
JNCE Stock Symbol:
Jounce Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment of former chief executive officer of Co...
Image source: The Motley Fool. Jounce Therapeutics, inc (NASDAQ: JNCE) Q2 2021 Earnings Call Aug 5, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Jounce Therapeutics, inc (JNCE) Q2 2021 Earnings Call Transcript
- INNATE monotherapy dose escalation enrollment completed and target dose selected, on track to initiate indication specific expansions in third quarter 2021- - Announced two additional LILRB family targets as potential future development candidates - - Ended the qu...